FDA Inspection 1191833 — Biokosmes Srl

Biokosmes Srl — FEI 3005488444

The FDA completed an inspection of Biokosmes Srl on December 2, 2022 in Bosisio Parini. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 9 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 2, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bosisio Parini (Italy)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
126321 CFR 211.68(b)Computer control of master formula records
145021 CFR 211.113(a)Procedures for non-sterile drug products
183321 CFR 211.84(d)(1)Identity Testing of Each Component
202021 CFR 211.188(b)(8)Labeling Control Records and Label Copies
358121 CFR 211.101(d)Verification of component addition
360321 CFR 211.160(b)Scientifically sound laboratory controls